7/9/2019China Accounted for 67% of India's Bulk Drug Imports in FY19

7/9/2019CDE Reports 47% Increase with Drug Applications in 2018

7/9/20192019 Rubio's Huawei Proposal Should Worry US Tech, Pharma Companies

7/9/2019UCSD Doctor Resigns After inewsource Raised Questions About His China ...

7/9/2019Fosun Pharma Picks Up GSK Plant in China along with Rights to Make Epi...

7/9/2019U.S. Seeks Extradition of Chinese Scientist in GSK Trade Secrets Case

7/8/2019Pfizer Launches Anticancer VIZIMPRO (dacomitinib) following Chinese A...

7/5/2019Recent Executive Moves

7/5/2019Syncore Set to Initiate Phase III Trial of Cancer Drug

7/5/2019Novartis Eyes Registration of 50 New Drugs in China Before 2023

7/5/2019China Approves Janssen‘s Anticancer DARZALEX (Daratumumab)

7/5/2019CDE Seeks Comments on Draft ICH Guideline E8(R1)

7/5/2019China Launches Pilot Mental Healthcare Program for Senior Citizens

7/4/2019China Approves Alteogen’s Herceptin Biosimilar for Clinical Trials

7/4/2019Incyte and Zai Lab Announce Collaboration and License Agreement for IN...

7/4/2019GSK Wins Chinese Approval of Lupus Drug BENLYSTA (belimumab)

7/4/2019CDE Solicits Comments on General Requirements for Oral Tablet Scoring ...

7/3/2019NHC Issues First Batch of the List of Drugs Subject To State Rationali...

7/2/2019CNIPA Issues 2019 Work Guidance on Promoting the High-Quality Developm...

7/1/2019CDE Publicizes Eight More Drug Applications To Be Granted Priority Rev...

7/1/2019Pilot Provinces Share Their Pioneering Healthcare Reform Experiences

7/1/2019China Adopts Vaccine Administration Law with Effect from Dec. 1, 2019

7/1/2019Tasly Biopharma Closes In on the Long-awaited $1Bln IPO

6/28/2019Financial-related Company News in Brief

6/28/2019BeiGene Approved to Transition from Biotech Chapter of HKEx to a Gener...

6/28/2019US-China Trade War Gets Mixed Reviews from Chinese Attendees at BIO

6/27/2019Who Will Win the PD-1 War in China?

6/27/2019Yisheng Biopharma Cleared for Clinical Trial of Anticancer YS-ON-001

6/27/2019Innovent-Eli Lilly Files NDA for Rituximab Biosimilar with NMPA

6/27/2019Johnson & Johnson Innovation Opens JLABS @ Shanghai

Page:304/803 Total number of articles:24088: [First][<<] [302] [303] [304] [305] [306] [>>] [End]